Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and laboratory features of the catastrophic antiphospholipid syndrome.

Clinical reviews in allergy & immunology - 1 Jun 2009

Stojanovich Ljudmila, Marisavljevic Dragomir, Rovensky Jozef, Djokovich Aleksandra, Kozáková Darina, Milinic Nikola

Abstract excerpt

Catastrophic antiphospholipid syndrome (CAPS, Asherson's syndrome) is an unusual form of antiphospholipid syndrome (APS) characterized by multi-organ failure and high mortality. Fortunately, CAPS accounts for less than 1% of APS cases. Due to the rarity of the condition, an international registry of CAPS patients was created in 2000 supported by the European Forum on Antiphospholipid Antibodies held in Taormina,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anticardiolipin
Share to Antiphospholipid Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyspnea

Share to Lupus Coagulation Inhibitor

Share to Molecular Mimicry

Share to Multiple Organ Failure

Share to Platelet Activation

Share to Respiratory Insufficiency

Source

Identifiers

PMID: 19052923
DOI: 10.1007/s12016-008-8108-8

Genes

CAPS
GPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and laboratory features of the catastrophic antiphospholipid syndrome.PMID 19052923Read ↗

Diagnosis and management of catastrophic antiphospholipid syndrome.Semantic proximity Read ↗

Catastrophic antiphospholipid syndrome accompanied by complement regulatory gene mutation.Semantic proximity Read ↗

What is antiphospholipid syndrome?Semantic proximity Read ↗

Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulatorsSemantic proximity Read ↗

Clinical and immunological characteristics of antiphospholipid syndrome in an Asian population: a retrospective study.Semantic proximity Read ↗

The Antiphospholipid SyndromeSemantic proximity Read ↗

Spectrum of juvenile antiphospholipid syndrome in two siblings: Case reports and review of literatureSemantic proximity Read ↗

[Antiphospholipid syndrome: pathophysiology and clinicobiological aspects].Semantic proximity Read ↗

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndromeSemantic proximity Read ↗

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?Semantic proximity Read ↗

Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.Semantic proximity Read ↗

A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.